文献速递脑血管病

年龄修饰社会经济弱势卒中人群取栓获益:RESILIENT试验亚组分析

Age Is an Effect Modifier of Thrombectomy Benefit in a Socioeconomically Vulnerable Stroke Population.
PubMed 文献 · Ann Neurol · 2026-07-24

该研究为巴西RESILIENT试验的预设亚组分析,比较血管内治疗与单纯药物治疗前循环大血管闭塞卒中。在221例患者中,年龄增长独立降低功能独立 odds,且年龄显著修饰取栓疗效:非老年患者获益显著,老年和非常老年患者获益减弱。

要点

  • 年龄增长与前循环大血管闭塞卒中90天功能独立 odds 降低独立相关。
  • 取栓疗效受年龄修饰:非老年患者显著获益,老年患者获益减弱。
  • 在资源有限公立医疗体系中,老年患者取栓获益可能 diminished。

核心结论

  • 在发展中国家公立医疗体系中,血管内治疗对老年大血管闭塞卒中患者的疗效显著减弱。

研究设计与样本

  • RESILIENT试验的预设亚组分析,为巴西多中心随机对照试验,比较血管内治疗与单纯药物治疗前循环大血管闭塞卒中。
  • 共纳入221例随机患者,47.1%为女性,NIHSS中位数18(IQR 14-21),老年(≥70岁)89例(40.2%),非常老年(≥80岁)37例(16.7%)。

主要发现

  • 年龄增长与全研究人群功能独立 odds 降低独立相关(OR 0.97;95%CI 0.95-0.99;p=0.01)。
  • 非老年患者从血管内治疗中显著获益(OR 4.08;95%CI 1.71-9.76)。
  • 老年患者取栓获益减弱(OR 0.90;95%CI 0.17-5.42;pinteraction=0.03)。
  • 非常老年患者取栓获益减弱(OR 0.36;95%CI 0.11-3.21;pinteraction=0.03)。

临床怎么用

  • 在资源有限公立医疗体系中,对老年大血管闭塞卒中患者选择取栓治疗时需个体化评估获益与风险。

局限性

  • 本研究为亚组分析,样本量有限,尤其非常老年患者仅37例。
  • 结果来自巴西公立医疗体系,外推至其他地区需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Randomized trials from high-income countries have shown that endovascular treatment (EVT) yields similar benefits in elderly and non-elderly patients with large vessel occlusion stroke (LVOS). However, evidence from low/middle-income countries remains scarce. We aimed to assess the impact of age on outcomes and determine whether age modifies the effect of EVT under the resource-limited conditions of a public healthcare system in a developing country. METHODS: Pre-specified subgroup analysis of the RESILIENT trial, a multicenter, randomized, controlled trial in Brazil comparing EVT versus medical treatment alone in anterior circulation LVOS. Patients were categorized as non-elderly (<70 years), elderly (≥70 years), and very elderly (≥80 years). The primary endpoint was functional independence (modified Rankin scale 0-2) at 90 days. Logistic regression was performed to identify independent predictors of outcome and to assess age as an effect modifier. RESULTS: Among 221 randomized patients (47.1% females; median [IQR] National Institutes of Health Stroke Scale, 18 [14-21]), 89 (40.2%) were elderly and 37 (16.7%) very elderly. Increasing age was independently associated with lower odds of functional independence in the entire study population (odds ratio [OR]: 0.97; 95% confidence interval [CI]: 0.95-0.99, p = 0.01). Age significantly modified the treatment effect of EVT. Non-elderly patients derived substantial benefit from EVT (OR: 4.08; 95% CI: 1.71-9.76), whereas the benefit was attenuated in elderly (OR: 0.90; 95% CI: 0.17-5.42; pinteraction = 0.03) and very elderly (OR: 0.36; 95% CI: 0.11-3.21; pinteraction = 0.03). INTERPRETATION: The effect of EVT appears significantly diminished among elderly patients in a public healthcare system in a developing country. Further studies are needed to understand the mechanism underlying these findings and properly assess the efficacy of EVT in this vulnerable population. ANN NEUROL 2026;100:644-652.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Lima FO, Mont'Alverne FJA, Rebello LC, et al. Age Is an Effect Modifier of Thrombectomy Benefit in a Socioeconomically Vulnerable Stroke Population. Ann Neurol. 2026. PMID: 42498265. doi:10.1002/ana.78281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。